Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: Is there a case for thoracic cytoreduction?
- 1 October 2013
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 131 (1), 27-31
- https://doi.org/10.1016/j.ygyno.2013.07.093
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Pleural Effusion Detected at CT prior to Primary Cytoreduction for Stage III or IV Ovarian Carcinoma: Effect on SurvivalRadiology, 2011
- Pathological Diagnosis and Cytoreduction of Cardiophrenic Lymph Node and Pleural Metastasis in Ovarian Cancer Patients Using Video-Assisted Thoracic SurgeryAnnals of Surgical Oncology, 2009
- Intra-thoracic cytoreduction of stage IV peritoneal malignancy: A case seriesGynecologic Oncology, 2008
- Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography—A prospective studyGynecologic Oncology, 2008
- Aggressive Surgical Effort and Improved Survival in Advanced-Stage Ovarian CancerObstetrics & Gynecology, 2006
- The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinomaCancer, 2005
- Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-AnalysisJournal of Clinical Oncology, 2002
- Identification of Prognostic Factors in Advanced Epithelial Ovarian CarcinomaGynecologic Oncology, 2001
- Current management of epithelial ovarian carcinoma: A reviewSeminars in Surgical Oncology, 2000
- Effect of Surgical Debulking on Survival in Stage IV Ovarian CancerGynecologic Oncology, 1997